Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.634
-0.020 (-3.03%)
At close: Apr 28, 2026, 4:00 PM EDT
0.650
+0.016 (2.49%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Envoy Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.24 | 0.23 | 0.32 | 0.24 | 0.31 |
| Revenue Growth (YoY) | 7.11% | -28.80% | 33.33% | -23.55% | - |
| Cost of Revenue | 0.68 | 0.74 | 0.79 | 0.5 | 0.77 |
| Gross Profit | -0.44 | -0.52 | -0.47 | -0.26 | -0.46 |
| Selling, General & Admin | 9.15 | 8.56 | 8.93 | 3.47 | 2.47 |
| Research & Development | 12.49 | 10.18 | 8.96 | 4.98 | 3.94 |
| Operating Expenses | 21.64 | 18.74 | 17.89 | 8.45 | 6.41 |
| Operating Income | -22.08 | -19.26 | -18.36 | -8.71 | -6.87 |
| Interest Expense | -1.59 | -0.82 | - | - | - |
| Other Non Operating Income (Expenses) | 0.1 | -0.72 | 1.77 | -0.13 | -1.8 |
| EBT Excluding Unusual Items | -23.57 | -20.8 | -16.59 | -8.83 | -8.67 |
| Gain (Loss) on Sale of Assets | - | - | - | - | -0 |
| Other Unusual Items | -0.19 | - | -13.33 | -7.09 | - |
| Pretax Income | -23.76 | -20.8 | -29.92 | -15.92 | -8.68 |
| Net Income | -23.76 | -20.8 | -29.92 | -15.92 | -8.68 |
| Preferred Dividends & Other Adjustments | 4.91 | 7.18 | 1.35 | - | - |
| Net Income to Common | -28.66 | -27.97 | -31.27 | -15.92 | -8.68 |
| Shares Outstanding (Basic) | 23 | 19 | 12 | 10 | 10 |
| Shares Outstanding (Diluted) | 23 | 19 | 12 | 10 | 10 |
| Shares Change (YoY) | 23.78% | 52.83% | 21.46% | -0.04% | - |
| EPS (Basic) | -1.23 | -1.49 | -2.54 | -1.57 | -0.86 |
| EPS (Diluted) | -1.23 | -1.49 | -2.54 | -1.57 | -0.86 |
| Free Cash Flow | -18.38 | -18.93 | -17.24 | -9.02 | -7.06 |
| Free Cash Flow Per Share | -0.79 | -1.01 | -1.40 | -0.89 | -0.70 |
| Gross Margin | -183.82% | -229.78% | -149.68% | -110.13% | -148.06% |
| Operating Margin | -9161.83% | -8558.22% | -5809.81% | -3673.42% | -2216.45% |
| Profit Margin | -11892.95% | -12432.44% | -9895.89% | -6718.56% | -2798.39% |
| Free Cash Flow Margin | -7626.56% | -8412.89% | -5456.96% | -3807.17% | -2277.74% |
| EBITDA | -21.78 | -19.08 | -18.23 | -8.63 | -6.8 |
| D&A For EBITDA | 0.3 | 0.17 | 0.13 | 0.08 | 0.07 |
| EBIT | -22.08 | -19.26 | -18.36 | -8.71 | -6.87 |
Source: S&P Capital IQ. Standard template.
Financial Sources.